998
Participants
Start Date
June 23, 2015
Primary Completion Date
April 12, 2019
Study Completion Date
April 12, 2019
ALIROCUMAB SAR236553 (REGN727)
Pharmaceutical form:solution Route of administration: subcutaneous
placebo (for injection training only)
Pharmaceutical form:solution Route of administration: subcutaneous
ezetimibe
Pharmaceutical form:capsule Route of administration: oral
atorvastatin
Pharmaceutical form:tablet Route of administration: oral
rosuvastatin
Pharmaceutical form:tablet Route of administration: oral
simvastatin
Pharmaceutical form:tablet Route of administration: oral
Investigational Site Number 040003, Vienna
Investigational Site Number 040002, Vienna
Investigational Site Number 056010, Brussels
Investigational Site Number 348001, Budapest
Investigational Site Number 040004, Vienna
Investigational Site Number 040007, Vienna
Investigational Site Number 040010, Vienna
Investigational Site Number 056003, Brussels
Investigational Site Number 705001, Maribor
Investigational Site Number 056018, Antwerp
Investigational Site Number 056007, Edegem
Investigational Site Number 056004, Leuven
Investigational Site Number 724011, Alicante
Investigational Site Number 056019, Genk
Investigational Site Number 056011, Overpelt
Investigational Site Number 056014, Liège
Investigational Site Number 208002, Roskilde
Investigational Site Number 040005, Linz
Investigational Site Number 040006, Linz
Investigational Site Number 348002, Debrecen
Investigational Site Number 756004, Reinach
Investigational Site Number 756002, Olten
Investigational Site Number 756005, Baden
Investigational Site Number 056006, Charleroi
Investigational Site Number 040008, Innsbruck
Investigational Site Number 056008, Arlon
Investigational Site Number 208001, Esbjerg
Investigational Site Number 348003, Szeged
Investigational Site Number 056002, Haine-Saint-Paul
Investigational Site Number 056009, La Louvière
Investigational Site Number 056013, Bruges
Investigational Site Number 756001, Zurich
Investigational Site Number 056015, Kortrijk
Investigational Site Number 056016, Roeselare
Investigational Site Number 056001, Ghent
Investigational Site Number 056017, Ghent
Investigational Site Number 208003, Aalborg
Investigational Site Number 756003, Sankt Gallen
Investigational Site Number 056005, Aalst
Investigational Site Number 300003, Ampelokipoi
Investigational Site Number 276001, Berlin
Investigational Site Number 203001, Prague
Investigational Site Number 250028, Marseille
Investigational Site Number 250048, Marseille
Investigational Site Number 250015, Caen
Investigational Site Number 724003, Córdoba
Investigational Site Number 724002, Santiago de Compostela
Investigational Site Number 724012, Donostia / San Sebastian
Investigational Site Number 724014, Donostia / San Sebastian
Investigational Site Number 246003, Turku
Investigational Site Number 250002, Dijon
Investigational Site Number 250040, Dijon
Investigational Site Number 724004, Madrid
Investigational Site Number 724008, Madrid
Investigational Site Number 724010, Madrid
Investigational Site Number 250032, Coudray
Investigational Site Number 724005, Málaga
Investigational Site Number 250049, Brest
Investigational Site Number 250039, Nîmes
Investigational Site Number 250025, Toulouse
Investigational Site Number 250046, Toulouse
Investigational Site Number 250045, Bordeaux
Investigational Site Number 250051, Pessac
Investigational Site Number 250024, Montpellier
Investigational Site Number 724007, Las Palmas de Gran Canaria
Investigational Site Number 250007, Tours
Investigational Site Number 250012, Grenoble
Investigational Site Number 250038, Grenoble
Investigational Site Number 276003, Magdeburg
Investigational Site Number 250006, Nantes
Investigational Site Number 250022, Nantes
Investigational Site Number 300002, Ioannina
Investigational Site Number 724006, Valencia
Investigational Site Number 724016, Valencia
Investigational Site Number 724015, Valladolid
Investigational Site Number 724017, Galdakao
Investigational Site Number 203002, Hradec Králové
Investigational Site Number 250010, Reims
Investigational Site Number 250042, Lille
Investigational Site Number 250047, Clermont-Ferrand
Investigational Site Number 250021, Bayonne
Investigational Site Number 203004, Brno
Investigational Site Number 203005, Uherské Hradiště
Investigational Site Number 250057, Lyon
Investigational Site Number 250019, Vénissieux
Investigational Site Number 250054, Bron
Investigational Site Number 250014, Paris
Investigational Site Number 250041, Paris
Investigational Site Number 250026, Paris
Investigational Site Number 250044, Paris
Investigational Site Number 250001, Paris
Investigational Site Number 250018, Rouen
Investigational Site Number 250035, Le Chesnay
Investigational Site Number 246001, Varkaus
Investigational Site Number 250027, Amiens
Investigational Site Number 703003, Bratislava
Investigational Site Number 703002, Bratislava
Investigational Site Number 250016, Avignon
Investigational Site Number 250011, Poitiers
Investigational Site Number 250031, Poitiers
Investigational Site Number 250037, Limoges
Investigational Site Number 250034, Auxerre
Investigational Site Number 250013, Corbeil-Essonnes
Investigational Site Number 250030, Bobigny
Investigational Site Number 250023, Saint-Mandé
Investigational Site Number 642-001, Timișoara
Investigational Site Number 642-002, Iași
Investigational Site Number 040001, Graz
Investigational Site Number 124028, Trois-Rivières
Investigational Site Number 250033, Jossigny
Investigational Site Number 250036, Lens
Investigational Site Number 250004, Lille
Investigational Site Number 250008, Rennes
Investigational Site Number 300001, Kallithea
Investigational Site Number 348004, Pécs
Investigational Site Number 124018, Calgary
Investigational Site Number 124015, Cambridge
Investigational Site Number 124002, Chicoutimi
Investigational Site Number 124027, Coquitlam
Investigational Site Number 124025, Edmonton
Investigational Site Number 124017, Halifax
Investigational Site Number 124013, Hamilton
Investigational Site Number 124008, London
Investigational Site Number 124026, Maple Ridge
Investigational Site Number 124020, Montreal
Investigational Site Number 124022, Montreal
Investigational Site Number 124032, Mount Pearl
Investigational Site Number 124005, Ottawa
Investigational Site Number 124024, Peterborough
Investigational Site Number 124003, Québec
Investigational Site Number 124019, Saint-Charles-Borromée
Investigational Site Number 124007, Sarnia
Investigational Site Number 124001, Sherbrooke
Investigational Site Number 124030, Smiths Falls
Investigational Site Number 124023, Toronto
Investigational Site Number 124014, Toronto
Investigational Site Number 124011, Vancouver
Investigational Site Number 124012, Victoria
Investigational Site Number 124031, Winnipeg
Investigational Site Number 124009, Woodstock
Investigational Site Number 250017, Nice
Investigational Site Number 250050, Vichy
Investigational Site Number 616005, Gdansk
Investigational Site Number 616003, Krakow
Investigational Site Number 616001, Lodz
Investigational Site Number 616004, Olsztyn
Investigational Site Number 616002, Warsaw
Investigational Site Number 642-003, Bucharest
Investigational Site Number 703001, Košice
Investigational Site Number 724009, Alicante
Investigational Site Number 724019, Elche
Investigational Site Number 724020, Inca
Investigational Site Number 724001, L'Hospitalet de Llobregat
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY